Roswell Biotechnologies Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:$37M
Lead Investor(s):N/A

City Ranking

Industry Ranking

State Ranking

Estimated Revenue & Financials

  • Roswell Biotechnologies's estimated annual revenue is currently $7.9M per year.(?)
  • Roswell Biotechnologies's estimated revenue per employee is $155,000
  • Roswell Biotechnologies's total funding is $37M.

Employee Data

  • Roswell Biotechnologies has 51 Employees.(?)
  • Roswell Biotechnologies grew their employee count by 2% last year.
  • Roswell Biotechnologies currently has 1 job openings.

Roswell Biotechnologies is a molecular electronics company transforming DNA sequencing with their new molecular electronics sequencing platform designed to deliver the disruptive performance required for future biomedical and industrial applications. The platform technology, ENDSeqᅢᄁ¬ダᅡᄁ (Electronic Nano-Device Sequencing), deploys single molecule sensor nanotechnology in a scalable semiconductor chip format, to deliver a dramatic reduction in the cost of genome-sequencing with unprecedented speed, accuracy and simplicity. Roswell is focused on delivering the molecular electronics chip and system that provides a $100, 1-hour whole human genome for use in precision medicine.